Medicines and Healthcare products Regulatory Agency
1: Authorisation Number | UK MIA(IMP) 49160 |
---|---|
2: Name of authorisation holder | ERAMOL (UK) LTD |
3: Address(es) of manufacturing site(s) |
ERAMOL (UK) LTD, UNIT 11, GATWICK METRO CENTRE, BALCOMBE ROAD, HORLEY, RH6 9GA, UNITED KINGDOM ERAMOL (UK) LTD, UNIT 9, NORTH DOWNS BUSINESS PARK, LIMEPIT LANE, DUNTON GREEN, SEVENOAKS, TN13 2TL, UNITED KINGDOM |
4: Legally registered address of authorisation holder | ERAMOL (UK) LTD, UNIT 9, NORTH DOWNS BUSINESS PARK, LIMEPIT LANE, DUNTON GREEN, SEVENOAKS, TN13 2TL, UNITED KINGDOM |
5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
6: Legal Basis of authorisation | |
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
8: Authorisation Date | 21/11/2024 |
9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
ERAMOL (UK) LTD, UNIT 11, GATWICK METRO CENTRE, BALCOMBE ROAD, HORLEY, RH6 9GA, UNITED KINGDOM
Human Investigational Medicinal Products
Authorised Operations |
MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
Part 1 - MANUFACTURING OPERATIONS |
[ 1.1 ] Sterile Investigational Medicinal Products |
[ 1.1.3 ] Batch certification |
[ 1.2 ] Non-sterile investigational medicinal products |
[ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) |
[ 1.2.1.1 ] Capsules, hard shell |
[ 1.2.1.5 ] Liquids for external use |
[ 1.2.1.6 ] Liquids for internal use |
[ 1.2.1.13 ] Tablets |
[ 1.2.2 ] Batch certification |
[ 1.3 ] Biological investigational medicinal products |
[ 1.3.2 ] Batch certification |
[ 1.3.2.5 ] Biotechnology products |
[ 1.5 ] Packaging |
[ 1.5.1 ] Primary packaging |
[ 1.5.1.1 ] Capsules, hard shell |
[ 1.5.1.2 ] Capsules, soft shell |
[ 1.5.1.13 ] Tablets |
[ 1.5.2 ] Secondary packaging |
Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
[ 2.2 ] Batch certification of imported medicinal products |
[ 2.2.1 ] Sterile Products |
[ 2.2.1.1 ] Aseptically prepared |
[ 2.2.1.2 ] Terminally sterilised |
[ 2.2.2 ] Non-sterile products |
[ 2.2.3 ] Biological medicinal products |
[ 2.2.3.5 ] Biotechnology products |
[ 2.3 ] Other Importation Activities |
[ 2.3.1 ] Site of Physical Importation |
[ 2.3.2 ] Importation of Intermediate which undergoes further processing |
[ 2.3.4 ] Other Importation of QP certified IMPs from a country on the 'approved country for import list |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
ERAMOL (UK) LTD, UNIT 9, NORTH DOWNS BUSINESS PARK, LIMEPIT LANE, DUNTON GREEN, SEVENOAKS, TN13 2TL, UNITED KINGDOM
Human Investigational Medicinal Products
Authorised Operations |
MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
Part 1 - MANUFACTURING OPERATIONS |
[ 1.1 ] Sterile Investigational Medicinal Products |
[ 1.1.3 ] Batch certification |
[ 1.2 ] Non-sterile investigational medicinal products |
[ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) |
[ 1.2.1.1 ] Capsules, hard shell |
[ 1.2.1.5 ] Liquids for external use |
[ 1.2.1.6 ] Liquids for internal use |
[ 1.2.1.13 ] Tablets |
[ 1.2.2 ] Batch certification |
[ 1.3 ] Biological investigational medicinal products |
[ 1.3.2 ] Batch certification |
[ 1.3.2.5 ] Biotechnology products |
[ 1.5 ] Packaging |
[ 1.5.1 ] Primary packaging |
[ 1.5.1.1 ] Capsules, hard shell |
[ 1.5.1.2 ] Capsules, soft shell |
[ 1.5.1.5 ] Liquids for external use |
[ 1.5.1.6 ] Liquids for internal use |
[ 1.5.1.13 ] Tablets |
[ 1.5.2 ] Secondary packaging |
[ 1.6 ] Quality control testing |
[ 1.6.3 ] Chemical/Physical |
Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
[ 2.1 ] Quality control testing of imported medicinal products |
[ 2.1.3 ] Chemical/Physical |
[ 2.2 ] Batch certification of imported medicinal products |
[ 2.2.1 ] Sterile Products |
[ 2.2.1.1 ] Aseptically prepared |
[ 2.2.1.2 ] Terminally sterilised |
[ 2.2.2 ] Non-sterile products |
[ 2.2.3 ] Biological medicinal products |
[ 2.2.3.5 ] Biotechnology products |
[ 2.3 ] Other Importation Activities |
[ 2.3.1 ] Site of Physical Importation |
[ 2.3.2 ] Importation of Intermediate which undergoes further processing |
[ 2.3.4 ] Other Importation of QP certified IMPs from a country on the approved country for import list |